Create Account

One Health helps you track and understand your health simply.

Create Account

One Health helps you track and understand your health simply.

CSF Phenylalanine

Body Fluids

Cerebrospinal fluid phenylalanineCNS phenylalanine (CSF)CSF Phe

Review status

Currently under review

Pending specialist review and validation.

What it shows

This test measures the amount of phenylalanine, an essential amino acid, in your cerebrospinal fluid. Cerebrospinal fluid surrounds your brain and spinal cord and can show what is happening within the central nervous system.

Your sample is collected during a lumbar puncture performed by a clinician. Measuring phenylalanine in cerebrospinal fluid can help evaluate how the body handles this amino acid within the brain environment, especially when inherited metabolic conditions or treatment questions are being considered.

Why it matters

Phenylalanine levels inside the brain can affect learning, mood, and nerve function. Doctors may order this test when there are neurologic symptoms, when an inborn error of metabolism such as phenylalanine hydroxylase deficiency is suspected, or when they need to understand whether current diet or medicines are effectively protecting the brain.

Results can support decisions about therapy, such as dietary management, large neutral amino acid therapy, or tetrahydrobiopterin treatment, and may be interpreted alongside blood tests and other cerebrospinal fluid studies. Knowing the status in cerebrospinal fluid helps tailor care to reduce risk of long term neurologic problems.

Understanding your results

Your clinician will interpret the result in the context of symptoms, diet, medicines, and blood phenylalanine levels. A higher value may point to limited control of the disorder, impaired transport or metabolism, or to a technical issue like blood contamination of the sample. A lower value can occur with very strict dietary intake, malnutrition, or certain therapies, and still needs to be weighed against your overall health and goals of care.

If the result does not fit the clinical picture, your team may confirm with a repeat sample, review how the specimen was collected and stored, and check related labs. Follow up can include adjusting diet, reassessing medication dosing, or pursuing genetic and metabolic evaluations. Your clinician will discuss practical next steps that match your situation.

Reference ranges

520 umol/L
All sexes
0 days – 150 years

Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.

Factors that could impact CSF Phenylalanine

  • Blood contamination during lumbar puncture

    Even small amounts of blood mixing with cerebrospinal fluid can raise phenylalanine artificially. Careful technique and discarding early drops help reduce this effect.

  • Recent protein intake and fasting status

    High dietary protein or recent meals can influence amino acid patterns. Your team may give collection timing advice to limit short term swings that complicate interpretation.

  • Medications and supplements

    Tetrahydrobiopterin therapy, large neutral amino acids, and phenylalanine supplements can change levels. Always share medication and supplement details with your clinician.

  • Specimen handling and storage

    Delayed processing, incorrect tube type, or improper freezing can alter amino acid stability. Laboratories follow strict protocols to preserve accurate concentrations.

  • Liver and overall metabolic health

    Liver dysfunction and other metabolic stresses can affect phenylalanine metabolism and transport, influencing cerebrospinal fluid values independent of diet.

  • Age and neurologic status

    Developmental stage and active neurologic disease may modify central amino acid handling, which your clinician considers when interpreting results.

2026

References

  1. McGill University Health Centre. (2015, February 04). CSF Phenylalanine (Task CD 693417). Laboratory reference ranges.
  2. Vockley, J., Andersson, H. C., Antshel, K. M., Braverman, N. E., Burton, B. K., Frazier, D. M., Mitchell, J., Smith, W. E., Thompson, B. H., & Berry, S. A. (2014). Phenylalanine hydroxylase deficiency: Diagnosis and management guideline. Genetics in Medicine, 16(2), 188–200. https://doi.org/10.1038/gim.2013.157 External link
  3. van Wegberg, A. M. J., MacDonald, A., Ahring, K., Bélanger-Quintana, A., Blau, N, Bosch, A. M., Burlina, A., Campistol, J., Feillet, F., Giżewska, M., Huijbregts, S. C. J., Kearney, S., Leuzzi, V., Muntau, A. C., Trefz, F. K., & van Spronsen, F. J. (2017). The complete European guidelines on phenylketonuria: Diagnosis and treatment. Orphanet Journal of Rare Diseases, 12, 162. https://doi.org/10.1186/s13023-017-0685-2 External link